EXPRESSCELLS, INC.

Profile

Company Names

EXPRESSCELLS, INC.

Addresses

3675 MARKET ST., SUITE 200, PHILADELPHIA, PA 19104

Phone Numbers

484-802-7419

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$1,790,500.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-10-23 
$590,500.00 
$650,000.00 
$59,500.00 
Equity 
1
2019-06-06 
$1,200,000.00 
$1,200,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TOM 
 
ANDERSON 
DIRECTOR
NOVINT TECHNOLOGIES INC   |  AMERICAN GEOTHERMAL CORPORATION, INC.   |  EXPRESSCELLS, INC.   |  DEVVSTREAM HOLDINGS INC.   |  TS-NANO, INC.   |  BITNOMIAL, INC.
SAJAD 
 
BILGRAMI 
DIRECTOR
EXPRESSCELLS, INC.
WENDY 
 
DICICCO 
DIRECTOR
QUENCH USA, INC.   |  CANNAPHARMARX, INC.   |  CENTINEL SPINE, LLC   |  CARMELL THERAPEUTICS CORP   |  RENOVACOR, INC.   |  IMVAX, INC.   |  EYEPOINT PHARMACEUTICALS, INC.   |  EXPRESSCELLS, INC.   |  AKARI THERAPEUTICS PLC
MATTHEW 
 
HANDEL 
EXECUTIVE OFFICER, DIRECTOR
EXPRESSCELLS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-04-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-23 
2019-09-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-06 
2019-06-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#